Nanomedicines for the prevention/reduction of vaginal transmission of HIV and chlamydia

dc.contributor.authorYang, Sidi
dc.contributor.examiningcommitteeGu, Xiaochen (Pharmacy) Zhong, Wen (Biosystems Engineering) Wu, Xiao Yu (University of Toronto)en_US
dc.contributor.supervisorHo, Emmanuel (Pharmacy)en_US
dc.date.accessioned2017-08-30T12:27:24Z
dc.date.available2017-08-30T12:27:24Z
dc.date.issued2013-04-10en_US
dc.date.issued2013-08-08en_US
dc.degree.disciplinePharmacyen_US
dc.degree.levelDoctor of Philosophy (Ph.D.)en_US
dc.description.abstractThe development of vaginal microbicides could provide women an accessible alternative to protect themselves against sexually transmitted infections (STIs). We developed an intravaginal nanomedicine for the active delivery of saquinavir (SQV) to CD4+ immune cells to prevent/reduce vaginal acquisition of HIV. The nanomedicine was prepared with poly(lactic-co-glycolic acid) (PLGA) and conjugated to anti-CD4 antibody, which could achieve a more than two-fold increase in the intracellular delivery of SQV in vitro without causing any cytotoxicity. In order to better combat vaginal transmission of HIV, we developed a dual-preventive pH-sensitive RNAi-based combination nanomicrobicide for the prevention/reduction of vaginal transmission of HIV by knocking down host factor CCR5 and viral protein Nef simultaneously. The nanomicrobicide possessed a pH-dependent release profile to prevent siRNA from releasing in acidic vaginal environment and release siRNA in neutral intracellular environment. We also proved that knocking down Nef could reactivate Nef-blocked autophagy in vitro and the nanomicrobicide significantly inhibited replication of HIV in vitro. Anti-CD4 antibody conjugation to the nanomicrobicide significantly improved the vaginal distribution and tissue uptake of siRNA, and allowed the nanomicrobicide to achieve targeted gene knockdown in intravaginal CD4+ cells in mice. We further expanded the application of antibody-conjugated nanomedicine in the area of intravaginal delivery of antibody. Herein, we used the system to deliver anti-α4β7 monoclonal antibody (α4β7 Ab) intravaginally as a potential microbicide against HIV. The α4β7 Ab-conjugated nanomedicine decreased the percentage of α4β7high CD4+ T cells and α4β7high CD3+ T cells by half in the vaginal tract of RM 72 hr after a single administration without detectable systemic distribution. In addition, we developed a siRNA-polyethyleneimine (PEI)-based nanomicrobicide with dual preventative activities of reducing bacterial binding and improving host autophagic degradation of bacteria as a potential strategy against vaginal infection of chlamydia trachomatis (C. trachomatis). Platelet derived growth factor-β (PDGFR-β), an irreversible bacterial binding factor on host cells, was knocked down by siRNA and autophagic degradation of C. trachomatis was improved by the introduction of PEI. By working together this dual preventative strategy resulted in 63% decrease of C. trachomatis inclusions in vitro without causing inflammation, apoptosis or reduction in cell viability.en_US
dc.description.noteOctober 2017en_US
dc.identifier.citationYang, S., et al., Advancements in the field of intravaginal siRNA delivery. J Control Release, 2013. 167(1): p. 29-39.en_US
dc.identifier.citationYang, S., et al., Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4+ immune cells. Int J Nanomedicine, 2013. 8: p. 2847-58.en_US
dc.identifier.urihttp://hdl.handle.net/1993/32393
dc.language.isoengen_US
dc.publisherELSEVIERen_US
dc.publisherDovePressen_US
dc.rightsopen accessen_US
dc.subjectMicrobicideen_US
dc.subjectHIVen_US
dc.subjectChlamydiaen_US
dc.subjectNanoparticleen_US
dc.subjectGelen_US
dc.titleNanomedicines for the prevention/reduction of vaginal transmission of HIV and chlamydiaen_US
dc.typedoctoral thesisen_US
local.subject.manitobayesen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Yang_Sidi.pdf
Size:
5.07 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.2 KB
Format:
Item-specific license agreed to upon submission
Description: